Ranibizumab as an adjunct to laser for macular edema secondary to branch retinal vein occlusion

Indian Journal of Ophthalmology

Volumn 60, Issue 4, 2012, Pages 263-266

  Azad, Rajvardhan ^a   Vivek, Kumar ^a   Sharma, Yograj ^a   Chandra, Parijat ^a   Sain, Siddarth ^a   Venkataraman, Anusha ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Branch retinal vein occlusion; laser; Lucentis; macular edema

Indexed keywords

MONOCLONAL ANTIBODY; RANIBIZUMAB;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FOLLOW UP; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; LOW LEVEL LASER THERAPY; MALE; METHODOLOGY; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; LASER THERAPY; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84864426358     PISSN: 03014738     EISSN: 19983689     Source Type: Journal    
DOI: 10.4103/0301-4738.98701     Document Type: Article

References (3)

1. The Branch Vein Occlusion Study Group. Argon Laser photocoagulation for macular edema in Branch vein occlusion. Am J Ophthalmol 1984;98:271-82.
2. Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle CA, et al.; BRAVO investigators. Ranibizumab for Macular Oedema following BRVO: Six month primary end point results of a phase 3 study. Ophthalmology 2010;117:1102-12.
3. Campochiaro PA, Hafiz G, Shah SM, Vguyen QD, Ying H, Do DV, et al. Ranibizumab for macular oedema due to retinal vein occlusions; implications of VEGF as a critical stimulator. Mol Ther 2008;16:791-9.